Novo Nordisk Ozempic sales expected to reach $17B in 2029
Mario Tama/Getty Images News Ozempic, Novo Nordisk (NVO's) top-selling drug, will reach $17 billion in annual sales by 2029 as it continues to dominate the diabetes market, according to a new report. Data analytics and consulting firm…
